Real Money's Paul Price explains how stock market fluctuations led to price swings as the S&P 500 moved between being overbought and oversold—and what that means

Goldman Sachs has put together a list of favored companies that it sees benefiting from 'the broadening of the digital revolution.'

Athira Pharma climbs on Alzheimer study news, while the CEO steps down over altered images in her research papers and dissertation.

Luxembourgers will be able to grow up to four cannabis plants in their homes.

A CDC director has signed off on extra doses, and on taking a Covid booster different from the original vaccine, in line with the U.S. FDA recommendations.

Simon Property firmed after Bank of America increased its price target for the country’s biggest shopping mall REIT to $165 from $150.

Snap, Intel, Moderna, Beyond Meat and Honeywell are five stocks that fell on Friday.

Intel stock is dropping after its earnings report, but a further 11% decline could be in the cards unless Intel holds a key support level.

Ocular Therapeutix shares lost a third of their market value after the biopharma's candidate for dry-eye disease missed its key endpoint.

The Dow posts its first record close since August as Fed Chair Powell says the central bank was on track to begin tapering the pace of its monthly bond purchases.